In Schneebaum et al. study [9], 19% of 269 patients with SLE demonstrated elevated levels of IgG or IgM anti-P antibodies, including 14% of 187 patients without and 29% of 82 patients with neuropsychiatric manifestations. The gene discussed is OCA2; the disease is systemic lupus erythematosus.